Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H26N4 |
Molecular Weight | 346.4686 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CC[C@@]23[C@@H]4NC5=C(C=CC=C5)[C@]2(CCN4C)[C@@H]1NC6=CC=CC=C36
InChI
InChIKey=XSYCDVWYEVUDKQ-GXRSIYKFSA-N
InChI=1S/C22H26N4/c1-25-13-11-22-16-8-4-5-9-17(16)23-19(25)21(22)12-14-26(2)20(22)24-18-10-6-3-7-15(18)21/h3-10,19-20,23-24H,11-14H2,1-2H3/t19-,20-,21-,22-/m1/s1
Molecular Formula | C22H26N4 |
Molecular Weight | 346.4686 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Calycanthine is the principal alkaloid of the family Calycanthaceae. Calycanthine is a central nervous system toxin, causing convulsions in animals. Calycanthine may mediate its convulsant action predominantly by inhibiting the release of the inhibitory neurotransmitter GABA as a result of interactions with L-type Ca(2+) channels and by inhibiting GABA-mediated chloride currents at GABA(A) receptors.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0014051 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12831783 |
|||
Target ID: CHEMBL2095229 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12831783 |
42.0 µM [IC50] | ||
Target ID: CHEMBL2095172 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12831783 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Convulsant actions of calycanthine. | 2003 Jul 1 |
|
Concise total synthesis of (-)-calycanthine, (+)-chimonanthine, and (+)-folicanthine. | 2007 |
|
Chemical constituents from leaves of Palicourea coriacea (Rubiaceae). | 2008 Jul |
|
Antifungal activity of alkaloids from the seeds of Chimonanthus praecox. | 2009 Jun |
Patents
Sample Use Guides
Median lethal dose of calycanthine in rodents: 43.79 mg/kg for mice, 17.16 mg/kg for rats
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1653964
Calycanthine hydrochloride (10 uM), which did not alter nervous conduction in pre- and post-synaptic fibers, significantly reduced the efficacy of the synaptic transmission in giant axons of the cockroach (Periplaneta americana).
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:04:18 GMT 2023
by
admin
on
Sat Dec 16 09:04:18 GMT 2023
|
Record UNII |
F62N8QPR7V
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3333
Created by
admin on Sat Dec 16 09:04:18 GMT 2023 , Edited by admin on Sat Dec 16 09:04:18 GMT 2023
|
PRIMARY | |||
|
m2995
Created by
admin on Sat Dec 16 09:04:18 GMT 2023 , Edited by admin on Sat Dec 16 09:04:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
209-857-7
Created by
admin on Sat Dec 16 09:04:18 GMT 2023 , Edited by admin on Sat Dec 16 09:04:18 GMT 2023
|
PRIMARY | |||
|
F62N8QPR7V
Created by
admin on Sat Dec 16 09:04:18 GMT 2023 , Edited by admin on Sat Dec 16 09:04:18 GMT 2023
|
PRIMARY | |||
|
595-05-1
Created by
admin on Sat Dec 16 09:04:18 GMT 2023 , Edited by admin on Sat Dec 16 09:04:18 GMT 2023
|
PRIMARY | |||
|
5392245
Created by
admin on Sat Dec 16 09:04:18 GMT 2023 , Edited by admin on Sat Dec 16 09:04:18 GMT 2023
|
PRIMARY | |||
|
99016
Created by
admin on Sat Dec 16 09:04:18 GMT 2023 , Edited by admin on Sat Dec 16 09:04:18 GMT 2023
|
PRIMARY | |||
|
DTXSID10974900
Created by
admin on Sat Dec 16 09:04:18 GMT 2023 , Edited by admin on Sat Dec 16 09:04:18 GMT 2023
|
PRIMARY |